Is Azenta Inc (AZTA) overvalued? · rev $159.2M
Azenta Inc (AZTA) is a medical instruments & supplies company listed on US.
This page asks whether Azenta Inc (AZTA) looks expensive on cached numbers — not a short thesis.
Latest reported AZTA revenue for 2025-09-30 was $159.2M. Net income was $50.9M. Revenue was up 10.7% from 2025-06-30 to 2025-09-30. AZTA currently screens at market cap $1.05B.
AZTA currently screens at market cap $1.05B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next AZTA 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the AZTA stock page for the full model, not this heading.
Not investment advice.